Literature DB >> 20970246

Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.

Jean-Nicolas Cornu1, Géraldine Cancel-Tassin, Valérie Ondet, Caroline Girardet, Olivier Cussenot.   

Abstract

BACKGROUND: Volatiles organic compounds (VOCs) in urine have been proposed as cancer biomarkers.
OBJECTIVE: To evaluate the efficacy of prostate cancer (PCa) detection by trained dogs on human urine samples. DESIGN, SETTING, AND PARTICIPANTS: A Belgian Malinois shepherd was trained by the clicker training method (operant conditioning) to scent and recognize urine of people having PCa. All urine samples were frozen for preservation and heated to the same temperature for all tests. After a learning phase and a training period of 24 mo, the dog's ability to discriminate PCa and control urine was tested in a double-blind procedure. Urine was obtained from 66 patients referred to a urologist for elevated prostate-specific antigen or abnormal digital rectal examination. All patients underwent prostate biopsy and two groups were considered: 33 patients with cancer and 33 controls presenting negative biopsies. MEASUREMENTS: During each "run," the dog was asked to signal a cancer urine among six samples containing only one cancer urine and five randomly selected controls. Sensitivity and specificity of the test were assessed. RESULTS AND LIMITATIONS: The dog completed all the runs and correctly designated the cancer samples in 30 of 33 cases. Of the three cases wrongly classified as cancer, one patient was rebiopsied and a PCa was diagnosed. The sensitivity and specificity were both 91%.
CONCLUSIONS: This study shows that dogs can be trained to detect PCa by smelling urine with a significant success rate. It suggests that PCa gives an odor signature to urine. Identification of the VOCs involved could lead to a potentially useful screening tool for PCa. Copyright Â
© 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970246     DOI: 10.1016/j.eururo.2010.10.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  61 in total

Review 1.  [Prostate cancer].

Authors:  J Noldus
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Xibei Jia; Ruichan Liu
Journal:  Med Princ Pract       Date:  2017-06-19       Impact factor: 1.927

3.  A detection dog for obstructive sleep apnea.

Authors:  Anni Koskinen; Adel Bachour; Jenni Vaarno; Heli Koskinen; Sari Rantanen; Leif Bäck; Tuomas Klockars
Journal:  Sleep Breath       Date:  2018-05-24       Impact factor: 2.816

4.  Canine olfactory detection of malignant melanoma.

Authors:  Leon Frederick Campbell; Luke Farmery; Susannah Mary Creighton George; Paul B J Farrant
Journal:  BMJ Case Rep       Date:  2013-10-14

5.  Animal instinct helps doctors ferret out disease.

Authors:  Michelle Pflumm
Journal:  Nat Med       Date:  2011-02       Impact factor: 53.440

6.  Dances with dogs: interspecies play and a case for sympoietic enactivism.

Authors:  Michele Merritt
Journal:  Anim Cogn       Date:  2021-01-12       Impact factor: 3.084

7.  Integrating exhaled breath diagnostics by disease-sniffing dogs with instrumental laboratory analysis.

Authors:  Joachim Pleil; Roger Giese
Journal:  J Breath Res       Date:  2017-09-07       Impact factor: 3.262

Review 8.  Genetics of canine olfaction and receptor diversity.

Authors:  Pascale Quignon; Maud Rimbault; Stéphanie Robin; Francis Galibert
Journal:  Mamm Genome       Date:  2011-11-13       Impact factor: 2.957

Review 9.  Exhaled breath analysis for lung cancer.

Authors:  Annette G Dent; Tom G Sutedja; Paul V Zimmerman
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

10.  The evolution of surgical treatment for gastrointestinal cancers.

Authors:  Yoshihiko Maehara; Yuji Soejima; Tomoharu Yoshizumi; Naoyuki Kawahara; Eiji Oki; Hiroshi Saeki; Tomohiko Akahoshi; Toru Ikegami; Yo-Ichi Yamashita; Tadashi Furuyama; Keishi Sugimachi; Noboru Harada; Tetsuzo Tagawa; Norifumi Harimoto; Shinji Itoh; Hideto Sonoda; Koji Ando; Yuichiro Nakashima; Yoshihiro Nagao; Nami Yamashita; Yuta Kasagi; Takafumi Yukaya; Takeshi Kurihara; Ryosuke Tsutsumi; Shinkichi Takamori; Shun Sasaki; Tetsuo Ikeda; Yoshikazu Yonemitsu; Takasuke Fukuhara; Hiroyuki Kitao; Makoto Iimori; Yuki Kataoka; Takeshi Wakasa; Masami Suzuki; Koji Teraishi; Yasuto Yoshida; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2019-09-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.